Generic Sweden AB (SE:GENI)

:GENI

GENI

Generic Sweden AB

RESEARCH TOOLSreports

Want to see SE:GENI full AI Analyst Report?

Generic Sweden AB (GENI) Price & Analysis

1 Followers

GENI Stock Chart & Stats

kr46.45

-kr0.40(-0.70%)

At close: Mar 06 4:00 PM EST

kr46.45

-kr0.40(-0.70%)

Day’s Range― - ―

52-Week Rangekr33.50 - kr62.50

Previous CloseN/A

Volume12.15K

Average Volume (3M)20.09K

Market Cap

kr481.85M

Enterprise Valuekr426.09M

Total Cash (Recent Filing)kr58.24M

Total Debt (Recent Filing)kr0.00

Price to Earnings (P/E)13.6

Beta0.46

Next Earnings

Aug 20, 2026

EPS Estimate

0.62

Next Dividend Ex-DateN/A

Dividend Yield3.48%

Share Statistics

EPS (TTM)2.52

Shares Outstanding12,292,020

10 Day Avg. Volume18,353

30 Day Avg. Volume20,086

Financial Highlights & Ratios

PEG Ratio1.31

Price to Book (P/B)8.56

Price to Sales (P/S)3.10

P/FCF Ratio14.63

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)2.71

Revenue Forecast (FY)kr196.00M

Bulls Say, Bears Say

Bulls Say

Debt-free Balance SheetZero reported debt materially lowers financial risk and preserves strategic optionality. With equity rising to 66.6M (2025) from 22.0M (2020), the firm can fund organic growth, product investment, dividends or M&A without relying on external leverage, supporting durable financial resilience.

Strong And Improving Free Cash FlowFree cash flow near parity with net income indicates high cash quality and that earnings convert to real liquidity. Robust FCF in 2025 strengthens capacity to fund capex, dividends and strategic initiatives internally, reducing dependence on financing and supporting sustainable capital allocation.

Sustained Revenue Growth And ProfitabilityA long run of revenue growth and a notable 2025 re-acceleration demonstrate product-market fit and scalable operations. Combined with mid-teens net margin and double-digit EBITDA margin, this indicates the business can grow sales while maintaining structural profitability over the medium term.

Bears Say

Gross Margin CompressionDeclining gross margins over several years suggest rising delivery costs or pricing pressure. Persisting gross margin erosion would reduce operating leverage and limit the ability to convert revenue growth into higher operating profits, forcing efficiency actions or price increases to sustain margins.

Historic Cash Conversion VariabilityEarlier periods show weaker cash conversion and a swingy free cash flow profile, implying working-capital or investment timing volatility. That variability can strain liquidity in downturns or constrain discretionary investments despite the strong 2025 outcome, making cash planning less predictable.

Uncertain Sustainability Of High ROEExtremely high historical ROE may not be sustainable if margins compress or reinvestment needs rise. Missing 2025 ROE data reduces visibility on whether past efficiency continues, making it harder to assess long-term capital returns and the durability of superior shareholder economics.

GENI FAQ

What was Generic Sweden AB’s price range in the past 12 months?

Generic Sweden AB lowest stock price was kr33.50 and its highest was kr62.50 in the past 12 months.

What is Generic Sweden AB’s market cap?

Generic Sweden AB’s market cap is kr481.85M.

When is Generic Sweden AB’s upcoming earnings report date?

Generic Sweden AB’s upcoming earnings report date is Aug 20, 2026 which is in 91 days.

How were Generic Sweden AB’s earnings last quarter?

Generic Sweden AB released its earnings results on May 13, 2026. The company reported kr0.63 earnings per share for the quarter, beating the consensus estimate of kr0.6 by kr0.03.

Is Generic Sweden AB overvalued?

According to Wall Street analysts Generic Sweden AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Generic Sweden AB pay dividends?

Generic Sweden AB pays a Annually dividend of kr1.6 which represents an annual dividend yield of 3.48%. See more information on Generic Sweden AB dividends here

What is Generic Sweden AB’s EPS estimate?

Generic Sweden AB’s EPS estimate is 0.62.

How many shares outstanding does Generic Sweden AB have?

Generic Sweden AB has 12,292,020 shares outstanding.

What happened to Generic Sweden AB’s price movement after its last earnings report?

Generic Sweden AB reported an EPS of kr0.63 in its last earnings report, beating expectations of kr0.6. Following the earnings report the stock price went up 12.061%.

Which hedge fund is a major shareholder of Generic Sweden AB?

Currently, no hedge funds are holding shares in SE:GENI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Generic Sweden AB

Generic Sweden AB, a technology company, provides messaging services for all applications. It also offers a platform for digital communication services. The company was incorporated in 1993 and is headquareted in Stockholm, Sweden.